- Home
- ADPT vs PRKS Comparison
ADPT vs PRKS Comparison
Compare ADPT & PRKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADPT | PRKS |
|---|---|---|
| Founded | 2009 | 1959 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.0B |
| IPO Year | 2019 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ADPT | PRKS |
|---|---|---|
| Price | $12.44 | $31.05 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $17.78 | ★ $48.09 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 05-05-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 3.06 |
| Revenue | $276,976,000.00 | ★ $1,263,324,000.00 |
| Revenue This Year | $3.98 | $3.88 |
| Revenue Next Year | $22.72 | $3.07 |
| P/E Ratio | ★ N/A | $10.67 |
| Revenue Growth | ★ 54.77 | N/A |
| 52 Week Low | $6.68 | $29.62 |
| 52 Week High | $20.76 | $56.95 |
Technical Indicators
Market Signals| Indicator | ADPT | PRKS |
|---|---|---|
| Relative Strength Index (RSI) | 24.22 | 33.93 |
| Support Level | $12.32 | $29.62 |
| Resistance Level | $13.45 | $37.12 |
| Average True Range (ATR) | 0.83 | 1.63 |
| MACD | -0.26 | -0.25 |
| Stochastic Oscillator | 10.61 | 0.87 |
Price Performance
Historical ComparisonAbout ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About PRKS United Parks & Resorts Inc.
United Parks & Resorts Inc is an American theme park and entertainment company. Its core business is the operation of theme parks and entertainment facilities involving sea animals across the country under prominent brands such as SeaWorld, Busch Gardens, Aquatica, Discovery Cove, and Sesame Place. The company generates the majority of its revenue from selling admission tickets for its theme parks.